JBS N.V. (JBS) Q4 2025 Earnings Call Transcript

JBS held its Q4 2025 earnings conference call on March 26, 2026 featuring CEO Gilberto Tomazoni and CFO Guilherme Cavalcanti (call excerpt provides participant list and standard forward-looking disclaimer). The provided excerpt contains no financial results, metrics, guidance, or material disclosures, so there is no immediate actionable information for portfolio positioning.

Analysis

JBS’s scale creates an option-like ability to shift volumes across geographies; that arbitrage amplifies when Brazilian exportable supply and a weak BRL align with stronger northern-hemisphere demand. Expect the bulk of the cross-border margin transfer to show up in global grind/trim and boxed-beef spreads over the next 2–3 quarters as shipments and channel mix adjust, which will mechanically compress US-only packers’ margins even if aggregate protein demand stays steady.

Second-order winners include Brazilian feed/transport providers (higher utilization) and global cold-chain logistics players that can scale refrigerated container flows; losers include mid‑sized US processors lacking export platforms and retailers that rely on short-term stable domestic supply. Key near-term catalysts that can amplify or reverse the move are: BRL moves of ±10% (translation + pricing power), an FMD/avian/pork disease event (weeks–months), and accelerated import inspections or anti-dumping actions (policy risk over months).

Downside tail risks are regulatory/antitrust pushback in large export destinations and a demand shock from discretionary-defensive consumer switching if retail prices spike — either could cut realized arbitrage and re-rate multiples within 1–2 quarters. The consensus underestimates how quickly integrated global capacity can redeploy: if JBS can redirect an incremental ~5–8% of production across borders in a quarter, that is sufficient to pressure cutout-driven US pricing materially, making a relative-value approach preferable to a naked long or short.

Trade implementation should emphasize optionality and relative exposure rather than outright directional exposure to protein prices; hedge FX and delivery timing explicitly because translation and cash realization profile are the dominant drivers of near-term earnings variance.

Key Decisions for Investors

• Pair trade: Long JBS (ticker: JBS) / Short Tyson Foods (ticker: TSN) equal-dollar notional, 3–9 month horizon. Rationale: play export-arbitrage and BRL tailwind vs US-focused packer exposure. Target 15–30% relative upside; stop-loss at 12% adverse divergence (stock price ratio basis).
• Options collar on JBS: Purchase 6–12 month call spread (buy a near-ATM to moderately OTM call, sell a higher OTM call ~30–60% above) sized to 2–4% of strategy NAV. Rationale: asymmetric upside to capture export/FX upside while capping premium cost. Risk = premium paid; target 40–80% payoff if arbitrage and BRL move favorably.
• FX hedge: Buy BRL upside (USD/BRL forwards or call options) for 3–12 months equivalent to expected Brazilian earnings exposure. Rationale: crystallizes currency tailwind and reduces translation volatility; cost is small relative to earnings sensitivity (each 10% BRL move changes reported EBITDA materially).
• Tactical protection: Buy 3–6 month puts on US mid‑cap packers (TSN/PPC if liquid) or use index-protective puts to hedge a demand shock over the next 60–120 days. Rationale: protects against a sudden retail pullback or regulatory interruption which would quickly reverse relative performance.